日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

结外弥漫性大B细胞淋巴瘤:多中心EXPECT研究的临床和分子见解及生存结果

Chen, Si-Yuan; Xu, Peng-Peng; Feng, Ru; Cui, Guo-Hui; Wang, Li; Cheng, Shu; Mu, Rong-Ji; Zhang, Hui-Lai; Wei, Xiao-Lei; Song, Yong-Ping; Ding, Kai-Yang; Dong, Li-Hua; Zhu, Zun-Min; Yang, Shen-Miao; Wang, Xin; Liu, Ting-Bo; Hu, Jian-Da; Zheng, Xiao-Yun; Bai, Ou; Xu, Jing-Yan; Huang, Liang; Sang, Wei; Shi, Ke-Qian; Zhou, Fan; Li, Fei; Liang, Ai-Bin; Zhou, Hui; Hao, Si-Guo; Huang, Hong-Hui; Xu, Bin; Qian, Wen-Bin; Li, Cai-Xia; Li, Zhi-Ming; Wu, Chong-Yang; Wang, Xiao-Bo; Shi, Wen-Yu; Wang, Shu-Ye; Tian, Yu-Yang; Zhang, Xi; Zhou, Ke-Shu; Cui, Li-Juan; Liu, Hui; Tan, Huo; Leng, Qing; Zhao, Dong-Lu; Niu, Ting; Zhao, Wei-Li

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma.

一项针对新发弥漫性大B细胞淋巴瘤的 2 期研究,评估 zanubrutinib 与利妥昔单抗和来那度胺联合用药的疗效。

Xu Peng-Peng, Zhu Yue, Shi Zi-Yang, Wang Li, Cheng Shu, Qian Ying, Zhao Yan, He Yang, Yi Hong-Mei, Ou-Yang Bin-Shen, Jiang Xu-Feng, Li Biao, Song Qi, Mu Rong-Ji, Zhao Wei-Li

Integration of gene mutations in risk prognostication for watch-and-wait follicular lymphoma patients initiating first-line treatment

将基因突变整合到观察等待策略下滤泡性淋巴瘤患者一线治疗的风险预后评估中

Xu, Tian-Yuan; Mu, Rong-Ji; Zhang, Hui-Lai; Xu, Bing; Li, Rong; Wang, Nan; Sun, Rui; Li, Rui-Chi; Fu, Di; Wang, Xian-Huo; Li, Zhi-Feng; Zhao, Yan; Xu, Peng-Peng; Cheng, Shu; Wang, Li; Tang, Wei; Zheng, Zhong; Zhao, Wei-Li

A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma

弥漫性大B细胞淋巴瘤预后指数:整合深度学习基线PET/CT生物标志物和多组学分析

Wang, Yue; Wang, Xue; Huang, Xin-Yun; Jing, Hong-Mei; Jiang, Song-Fu; Li, He; Mu, Rong-Ji; Shi, Qing; Fu, Di; Li, Zhuo-Han; Yi, Hong-Mei; Ouyang, Bin-Shen; Li, Biao; Yan, Fu-Hua; Niu, Ting; Cheng, Shu; Wang, Li; Wen, Ning; Xu, Peng-Peng; Zhao, Wei-Li

Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology.

利用数字病理学对弥漫性大B细胞淋巴瘤的微环境进行实用分类

Wang Yu-Qing, Wang Shuo, Yi Hong-Mei, Qian Ying, Wang Yue, Xu Hai-Min, Xu-Monette Zijun Y, Au Kelly, Tian Shuang, Dong Yan, Zhao Jing, Fu Di, Mu Rong-Ji, Wang Shu-Ye, Wang Li, Young Ken H, Xu Peng-Peng, Zhao Wei-Li

Different Role of PET-CT Evaluation in Newly Diagnosed Follicular Lymphoma Upon Rituximab-Based Chemotherapy and Chemo-Free Immunotherapy

PET-CT评估在接受利妥昔单抗化疗和无化疗免疫治疗的新诊断滤泡性淋巴瘤中的不同作用

Wang, Nan; Huang, Xin-Yun; Jiang, Xu-Feng; Wang, Li; Cheng, Shu; Xu, Peng-Peng; Dong, Lei; Ou-Yang, Bin-Shen; Mu, Rong-Ji; Li, Chen; Zhao, Yan; Feng, Yan; Dou, Hong-Jing; Zheng, Zhong; Zhao, Wei-Li

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma

弥漫性大B细胞淋巴瘤国际预后指数的生物学特征

Wang, Yue; Shi, Qing; Shi, Zi-Yang; Tian, Shuang; Zhang, Mu-Chen; Shen, Rong; Fu, Di; Dong, Lei; Yi, Hong-Mei; Ouyang, Bin-Shen; Mu, Rong-Ji; Cheng, Shu; Wang, Li; Xu, Peng-Peng; Zhao, Wei-Li

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial

正电子发射断层扫描指导的低危弥漫性大B细胞淋巴瘤治疗:一项随机、III期、非劣效性试验的结果

Shi, Qing; He, Yang; Yi, Hong-Mei; Mu, Rong-Ji; Jiang, Xu-Feng; Fu, Di; Dong, Lei; Qin, Wei; Xu, Peng-Peng; Cheng, Shu; Song, Qi; Chen, Sai-Juan; Wang, Li; Zhao, Wei-Li